Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (81-90 of 434) with videos related to

Pageof 44
Sort By:
Clinical and Experimental Rheumatology|September 10, 2019
Early development of new cardiovascular risk factors in the systemic vasculitidesSara Monti, Joanna Robson, Catherine Klersy, et al.
Arthritis Care & Research|April 1, 2011
Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitisMichael Walsh, Chetan Mukhtyar, Alfred Mahr, et al.
Arthritis Care & Research|June 20, 2020
Targeted Program in an Academic Rheumatology Practice to Improve Compliance With Opioid Prescribing Guidelines for the Treatment of Chronic PainEric J Wang, Rebecca Helgesen, Chadwick R Johr, et al.
Annals of Internal Medicine|March 5, 2014
Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort studyGunnar Tomasson, Christine Peloquin, Aladdin Mohammad, et al.
Journal of Medical Internet Research|March 14, 2023
Direct-to-Consumer Recruitment Methods via Traditional and Social Media to Aid in Research Accrual for Clinical Trials for Rare Diseases: Comparative Analysis StudyJanelle Applequist, Cristina Burroughs, Peter A Merkel, et al.
JAMA Dermatology|May 10, 2023
Assessment of Cutaneous Vasculitis and Quality of LifeSarah Mann, Aamir Hussain, Anisha B Dua, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
ReplyRobert G Micheletti, Zelma Chiesa Fuxench, Anthea Craven, et al.
Rheumatology (Oxford, England)|December 27, 2021
Obinutuzumab as treatment for ANCA-associated vasculitisNaomi A Amudala, Sara Boukhlal, Brittany Sheridan, et al.
The Journal of Rheumatology|July 15, 2003
Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6Peter A Merkel, Philip J Clements, John D Reveille, et al.
Orphanet Journal of Rare Diseases|May 20, 2016
The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research networkPeter A Merkel, Michele Manion, Rashmi Gopal-Srivastava, et al.
Pageof 44

Showing results (81-90 of 434) with videos related to

Sort By:
Pageof 44
Clinical and Experimental Rheumatology|September 10, 2019
Early development of new cardiovascular risk factors in the systemic vasculitidesSara Monti, Joanna Robson, Catherine Klersy, et al.
Arthritis Care & Research|April 1, 2011
Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitisMichael Walsh, Chetan Mukhtyar, Alfred Mahr, et al.
Arthritis Care & Research|June 20, 2020
Targeted Program in an Academic Rheumatology Practice to Improve Compliance With Opioid Prescribing Guidelines for the Treatment of Chronic PainEric J Wang, Rebecca Helgesen, Chadwick R Johr, et al.
Annals of Internal Medicine|March 5, 2014
Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort studyGunnar Tomasson, Christine Peloquin, Aladdin Mohammad, et al.
Journal of Medical Internet Research|March 14, 2023
Direct-to-Consumer Recruitment Methods via Traditional and Social Media to Aid in Research Accrual for Clinical Trials for Rare Diseases: Comparative Analysis StudyJanelle Applequist, Cristina Burroughs, Peter A Merkel, et al.
JAMA Dermatology|May 10, 2023
Assessment of Cutaneous Vasculitis and Quality of LifeSarah Mann, Aamir Hussain, Anisha B Dua, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
ReplyRobert G Micheletti, Zelma Chiesa Fuxench, Anthea Craven, et al.
Rheumatology (Oxford, England)|December 27, 2021
Obinutuzumab as treatment for ANCA-associated vasculitisNaomi A Amudala, Sara Boukhlal, Brittany Sheridan, et al.
The Journal of Rheumatology|July 15, 2003
Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6Peter A Merkel, Philip J Clements, John D Reveille, et al.
Orphanet Journal of Rare Diseases|May 20, 2016
The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research networkPeter A Merkel, Michele Manion, Rashmi Gopal-Srivastava, et al.
Pageof 44